Tirzepatide
Dual GIP/GLP-1 receptor agonist studied for weight management and glucose control.
About:
Tirzepatide is a dual GIP and GLP-1 receptor agonist that has become one of the most closely studied molecules in metabolic research. By engaging two incretin pathways at once, it is investigated for its effects on appetite signalling, insulin response, and body-weight regulation.
What does this peptide do?
Clinical research has explored its role in glucose control and substantial weight reduction, often comparing it against single-pathway GLP-1 agonists. Investigators are interested in how the combined mechanism influences satiety and energy balance.
Weight management
Trials in adults with obesity report body-weight reduction.
Glucose control
Trials in type 2 diabetes report HbA1c reduction.
Evidence grade
BHighest evidence grade among the graded claims: B. Grades reflect study strength, not benefit.
What are the benefits and side effects of this peptide
What research says it may help with
- Studied across a large randomized trial program in adults with obesity and type 2 diabetes.
- Trials report body weight and HbA1c reductions compared with placebo or active comparators.
Who should avoid it
- People who are pregnant or breastfeeding
- Children and adolescents
- People with a personal or family history of medullary thyroid carcinoma or MEN2
- People with a history of severe gastrointestinal disease, given the studied rate of gastrointestinal adverse events
- Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, a class-wide caution for GLP-1 and GIP receptor agonists
See the safety section. Absence of a flag is not evidence of safety.
A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.
How to store this peptide
Typically supplied as a prefilled subcutaneous injection pen requiring refrigeration before first use, with manufacturer guidance allowing a limited room-temperature window once in use. Products from unregulated compounding sources have not been evaluated for sterility or purity.
Lyophilized storage
Refrigerate at 2–8 °C in the original carton. Do not freeze.
Reconstituted storage
May be kept unopened at room temperature below 30 °C for up to 21 days; do not return it to the fridge.
Storage Handling
Protect from light. Do not use if it has been frozen.
Draw the exact dose, every time
Related research
Related peptides
MetabolicSemaglutide
GLP-1 receptor agonist researched for appetite regulation and metabolic health.
MetabolicRetatrutide
Triple-receptor agonist explored for next-generation weight management research.
MetabolicAICAR
AICAR is one of the most used laboratory activators of AMPK, and that identity is well documented in a systematic review. Disease model evidence,...